Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product

por Vanderlaan, Martin, Maniatis, Aristides, Olney, Robert, Rahmaoui, Abdelkader, Yau, Linda, Quarmby, Valerie, Azzolino, Craig, Woods, Cynthia, Moawad, Dalia
Publicado 2019

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H(1) Antihistamines: A Randomized, Placebo-Controlled Study

por Saini, Sarbjit S, Bindslev-Jensen, Carsten, Maurer, Marcus, Grob, Jean-Jacques, Bülbül Baskan, Emel, Bradley, Mary S, Canvin, Janice, Rahmaoui, Abdelkader, Georgiou, Panayiotis, Alpan, Oral, Spector, Sheldon, Rosén, Karin
Publicado 2015